ARCHIVES

Upon, Panel Lean To Anecdotal Laetrile Study

This article is from The Cancer Letter archive.

Vol. 03 No. 32 | August 12, 1977

Download PDF Visit The Full Archive

Related Articles

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

ASCO, AACI Ask $1.3 Billion for NCI, Full Funding Of Center Core, Group Grants

May 4, 1984

ACS Says 41 Percent Survive 5 Years

January 2, 1981

ACS Says Its Goals, Patients’ Coalition, Similar, Supports Bill

March 15, 1996

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

Oxford Univ. Receives Funds To Create Drug Design Center.

October 6, 2000